Nathaniel Jonathan Berky: New Protein-Binding Insight May Transform Personalised IVF
Nathaniel Jonathan Berky, Venture Architect, shared a post on LinkedIn:
“This is an important advance for reproductive health.
Understanding fertilisation at this molecular-mechanical level brings us closer to a truly personalised IVF journey in which fit-for-purpose treatment (rather than ‘unexplained’) can be identified within a failed cycle.
If this protein-binding mechanism can be verified in the clinic, it could shorten the trial and error aspect of treatment, improve IVF success rates, and change how we screen patients to prepare them for a cycle.
Switzerland is well placed for this next stage: we have good research (Basel, ETH-Department of Biosystems Science and Engineering (D-BSSE)), the biotech translation capacity, and a patient group who would expect evidence-based care than just fertility standard protocols.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 15, 2026, 08:18MHR Calls for Papers on Organoids, Assembloids and Emerging 3D Reproductive Models – ESHRE
-
Mar 15, 2026, 08:10This Month’s F and S On Air Podcast Episode Has Been Posted – Fertility and Sterility
-
Mar 15, 2026, 07:10Thomas McDonnel: Beta-2-Glycoprotein I Beyond Antibodies and APS
-
Mar 15, 2026, 06:52Fostamatinib as a Potential Treatment for APS-Related Thrombocytopenia – British Journal of Haematology
-
Mar 15, 2026, 06:49Does Endometrial Injury Improve Pregnancy Outcomes? – RBMO
-
Mar 15, 2026, 06:45Ultrasound Monitoring and Ovulation Trigger in IUI – Fertility and Sterility
-
Mar 15, 2026, 06:40Uterus Transplantation in Focus at Upcoming ESHRE Webinar – ESHRE
-
Mar 15, 2026, 06:34Abinet Gadissa: Patience Rewards the Scan in Fetal Echocardiography
-
Mar 15, 2026, 05:48RBMO Shares New Findings on Cell Number Biopsied During PGT-A